eCliniqua Social Links


Clinical News & Analysis

Search Text
Start Date
End Date

ClinTec Expands to Middle East, North Africa

| Business Insider | CRO firm ClinTec International has opened an office in Istanbul. Now operating in 40 countries, ClinTec's Turkey office will further consolidate its presence in the Middle East and North Africa.

Singapore Launches New Flu Vaccine Trial

| MedicalXpress | Singapore's A*STAR and Swiss group Cytos Biotechnology have launched a Phase 1 clinical trial for an H1N1 flu vaccine, making use of Cytos’ virus-like particle (VLP) technology.

Building Enthusiasm for Clinical Trials

| PhysBizTech | Using a trial search engine and educational web videos, researchers at the Seidman Cancer Center at Case Western Reserve University School of Medicine have been looking into ways to help build enthusiasm for clinical trials from both patients and practitioners.

Convergence and Big Data: Conversations from the Post-Approval Summit

| Clinical Informatics News | Dr. Richard Gliklich, President of the Quintiles Outcome Division of Quintiles, gave Clinical Informatics News a summary of conversations and issues raised at the 2013 Post-Approval Summit.

MIT Develops Insulin-Releasing Nanoparticles

| Diabetes News | Massachusetts Institute of Technology (MIT) researchers recently developed injectable nanoparticles for patients with type 1 diabetes. These nanoparticles are designed to replace the function of islet cells.

Generics Fraud: An Investigation

| CNN Money | Excellent reporting into the long-term criminal fraud at Ranbaxy—the Indian drug company that makes generic Lipitor.

Certara, Veristat Form Alliance to Streamline Discovery, Trial Process

| eCliniqua | Certara and Veristat have formed an alliance to offer pharmacokinetic (PK) analysis, PK /pharmacodynamic (PD) modeling, population PK modeling, trial simulation, clinical biostatistics, medical writing, data management, clinical monitoring, safety management, and project management to their clients.

Instem Acquires Logos Technologies, Plans SaaS Offering

| eCliniqua News Brief | Instem has acquired Logos Technologies, representing its strategic move into the early phase clinical trials market. Logos’ ALPHADAS software solution suite is a proactive eSource clinical trials system that is mobile, schedule-driven, and provides real-time bedside or station based direct data capture.

Bacteria Detection Device Could ID Pathogens at Bedside

| Forbes | Using DNA hybridization and detection with a miniaturized nuclear magnetic resonance (NMR) device about the size of a microscope slide, researchers are able to test for several bacterial pathogens at once within hours.

Breast Cancer Trials Test Several Therapies at Once

| OncLive | The I-SPY trials for breast cancer are aiming to test several experimental therapies at once to determine which ones work best in which patients.

Moffitt Uses Biosamples to Improve Trial Efficiency

| News Medical | According to researchers at Total Care Cancer (a comprehensive approach to cancer launched at Moffitt Cancer Center), using biosamples for phase II cancer trials improves research efficiency, cost, and the rate of drug development.

Merge EDC Solution Deployed by South African CRO

| PBR | OnQ Research, a South Africa-based Clinical Research Organization, has selected Merge's eClinical OS solution for electronic data capture to expand their in-house data management service offering.

Quintiles' IPO Raises $947m

| Med City News | Quintiles' second IPO yesterday raised $947 million. The offering prices Quintiles at $6.6 billon, 70% larger than the next largest CRO--Covance.

PRO-ACT: Bigger and Better ALS Database Open for Mining

| eCliniqua | Amyotrophic lateral sclerosis (ALS) research is getting a major boost from a newly launched Pooled Resource Open-access ALS Clinical Trials (PRO-ACT) platform, which has amassed more than 8,500 de-identified clinical patient records into a single, harmonized dataset. Multiple pharmaceutical companies are now actively exploring PRO-ACT, seeking ways to streamline clinical trials and develop better treatments for the rare and highly heterogeneous disease more commonly known as Lou Gehrig’s disease.

Genomic Prostate Cancer Test Gauges Tumor Aggressiveness

| Boston Herald | A new genetic test—Oncotype DX Genomic Prostate Score—purports to gauge the aggressiveness of prostate cancer, helping doctors and patients decide if they should their cancer right away or can safely monitor it.

Vanderbilt Launches Health App Contest

| eCliniqua News Brief | Vanderbilt University launched a $20,000 worldwide Health App Challenge last week, aimed to transform patient clinical summaries into easy to understand personalized health information.

EMC Offers Enhanced Life Sciences Suite

| eCliniqua | EMC announced new solutions at its EMC World event leveraging the EMC Documentum platform to meet compliance requirements, increase productivity and securely collaborate across the extended enterprise while accelerating time to value and reducing the total cost of ownership.

CIO of University of Utah Health Care Talks Trends

| Computerworld | Jim Turnbull, CIO at University of Utah Health Care in Salt Lake City, talks about how IT is changing healthcare, recruiting health IT talent, and the next big opportunities.

EMA Announces Reorganization Details

| eCliniqua | The first details of the planned reorganization of the European Medicines Agency (EMA) were announced this morning. The changes reflect a renewed focus on three key elements: how to better support the scientific work of the EMA committees, how to better share the data the Agency holds and how to better meet the needs of its stakeholders and partners.

Smartphones for Monitoring Parkinson's Patients

| eWeek | The Michael J. Fox Foundation (MJFF) for Parkinson's Research has been seeking insights on how mobile data can aid Parkinson's patients. LIONsolver, which stands for Learning and Intelligent Optimization Solver, won the foundation’s February; challenge to encourage use of patient data from smartphones for monitoring and treatment of Parkinson's.
 1        



For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.